PDUFA VII: FDA, Industry Agree To Set Minimum Carryover Balance Levels
The minimum total will increase from eight weeks of operating expenses in FY 2023 to 10 weeks by FY 2025.
You may also be interested in...
The US FDA, HHS and White House, as well as industry groups, now must sign off on the document.
Agency cites “unexpected and large drop in collections” in slashing user-fee-setting contract.
A proposed pilot program would offer for “split submission and review” of some application sections in other disease areas. Discussions also touch on concept of a CDER-CBER RWE committee.